Harrisburg, NC -- (SBWire) -- 02/20/2019 --The global market for opioid drugs should reach $29.8 billion by 2023 from $26.4 billion in 2018 at a compound annual growth rate (CAGR) of 2.5% for the period of 2018-2023.

The report tracks the major market events including product launches, development trends, mergers & acquisitions, and the innovative business strategies opted by key market players. Along with strategically analyzing the key markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Opioid Drugs Market.

Profiles of major companies in the industry, including: Acura Pharmaceuticals Inc., Cipher Pharmaceutical Inc., Daiichi Sankyo Inc., Johnson & Johnson, Lupin Ltd., Pfizer Inc., Sun Pharmaceuticals and Teva Pharmaceutical Industries Ltd.

Request a sample copy of this report at:
https://www.marketinsightsreports.com/reports/01071047297/opioid-drugs-global-markets-to-2023/inquiry?source=releasewire&Mode=07

Essential points covered in Global Opioid Drugs Market 2018 Research are:-
- What will the market size and the growth rate be in 2023?
- What are the key factors driving the Global Opioid Drugs market?
- What are the key market trends impacting the growth of the Global Opioid Drugs market?
- What are the challenges to market growth?
- Who are the key vendors in the Global Opioid Drugs market?
- What are the market opportunities and threats faced by the vendors in the Global Opioid Drugs market?
- What are the key outcomes of the five forces analysis of the Global Opioid Drugs market?

This report provides a detailed analysis of the Opioid Drugs market with description of market sizing and growth, segmentation of market by products & services and major markets, top market players etc. The report recapitulates the factors that will be responsible for the growth in the market in the forecasted period.

SPECIAL OFFER (Avail a flat 15% discount on this report, please fill the form and mention the code: MIR15 in the comments section)

Inquire for Discount:
https://www.marketinsightsreports.com/reports/01071047297/opioid-drugs-global-markets-to-2023/discount?source=releasewire&Mode=07

Report Includes:

- 20 data tables and 38 additional tables
- An overview of the global market for opioid drugs
- Analyses of global market trends, with data from 2017 to 2018, and projections of compound annual growth rates (CAGRs) through 2023
- Discussion of types, mode of action and receptor target of opioids drugs i.e. Mu receptor, Delta receptor and Kappa receptor
- Details of technological advancement for new opioid formulation to reduce the risk of drug abuse
- Case study of opioid addiction, opioid abuse and overdose and significant events addressing opioid misuse and abuse
- Information on stringent regulatory policies and government guidelines to impede the adoption rate of the opioid drugs
- Insights of new safety measures announced for immediate release (IR) opioids and CDC guidelines on prescribing opioids for chronic pain
- Company profiles of the major players of the market, including Acura Pharmaceuticals Inc., Cipher Pharmaceutical Inc., Daiichi Sankyo Inc., Johnson & Johnson, Lupin Ltd., Pfizer Inc., Sun Pharmaceuticals and Teva Pharmaceutical Industries Ltd.

Report Scope

The current report offers a detailed picture of the prescription opioid drug market. Prescription opioids are included in the scope of study; illegal opioids such as heroin, which are sold in illegal market for illicit usage, are not included. The market estimation includes all branded and generic opioid drugs indicated for different therapeutic application such as pain management and opioid use disorders.

This report highlights the current and future market potential of opioid drugs along with detailed analyses of the competitive environment, regulatory scenario, pipeline analysis, technological advancement and market dynamics.

The report details market shares of opioid drugs based on product and geography. Based on product, the market is segmented into buprenorphine, fentanyl, hydrocodone, morphine, oxycodone, tramadol and others. Each product segment includes detailed analyses covering an overview of drug, mechanism of action and market insights on each drug.

By geography, the market has been segmented into North America, Europe, Asia-Pacific, South America, and the Middle East and Africa. Detailed analyses of major countries such as the U.S., Germany, the U.K. France, Japan, China and India are covered in regional segments. For market estimates, data has been provided for the year 2017 and the base year of 2018 and forecast for 2023. Estimated values used are based on drug manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

Browse full report at:
https://www.marketinsightsreports.com/reports/01071047297/opioid-drugs-global-markets-to-2023?source=releasewire&Mode=07

The research includes historic data from 2013 to 2019 and forecasts until 2023 which makes the report an invaluable resource for industry executives, marketing, sales and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.

The report will make detailed analysis mainly on above questions and in-depth research on the development environment, market size, development trends, operation situation and future development trends of Opioid Drugs on the basis of current situation of the industry in 2018 so as to make judgment on the competitive situation of Opioid Drugs Market and assist manufacturers and investment organization to better grasp the development course of Opioid Drugs Market.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Contact Us:
Irfan Tamboli (Head of Sales) – Market Insights Reports
Phone: + 1704 266 3234
Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com